Journal of Chemotherapy

Papers
(The H4-Index of Journal of Chemotherapy is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis22
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA220
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer20
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis17
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database17
YAP/TAZ axis was involved in the effects of metformin on breast cancer16
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem16
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients15
Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study14
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer13
The use of antiviral drugs in children12
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam12
Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy12
0.078545808792114